Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-7 of  7 results for ""Bazzo ML""

Your Filters

Subject : anti-bacterial agents Subject : microbial sensitivity tests Filter by : Author
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Recent dynamics in Neisseria gonorrhoeae genomic epidemiology in Brazil: antimicrobial resistance and genomic lineages in 2017-20 compared to 2015-16.

Subjects: Neisseria gonorrhoeae*/Neisseria gonorrhoeae*/Neisseria gonorrhoeae*/genetics ; Neisseria gonorrhoeae*/Neisseria gonorrhoeae*/Neisseria gonorrhoeae*/drug effects ; Neisseria gonorrhoeae*/Neisseria gonorrhoeae*/Neisseria gonorrhoeae*/classification

  • Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 May 02; Vol. 79 (5), pp. 1081-1092.Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015-16.

Subjects: Drug Resistance, Multiple, Bacterial* ; Microbial Sensitivity Tests* ; Sentinel Surveillance*

  • Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2018 Jul 01; Vol. 73 (7), pp. 1854-1861.Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Serum Complement Activation by C4BP-IgM Fusion Protein Can Restore Susceptibility to Antibiotics in Neisseria gonorrhoeae .

  • Authors : Bettoni S; Department of Translational Medicine, Lund University, Malmö, Sweden.; Maziarz K

Subjects: Complement Activation*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*pharmacology ; Complement C4b-Binding Protein/Complement C4b-Binding Protein/Complement C4b-Binding Protein/*administration & dosage

  • Source: Frontiers in immunology [Front Immunol] 2021 Sep 01; Vol. 12, pp. 726801. Date of Electronic Publication: 2021 Sep 01 (Print Publication: 2021).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

IncX4 Plasmid-Mediated mcr-1.1 in Polymyxin-Resistant Escherichia coli from Outpatients in Santa Catarina, Southern Brazil.

  • Authors : Zamparette CP; Department of Clinical Analysis, Health Sciences Center, Federal University of Santa Catarina, Florianopolis, Brazil.; Schorner M

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*pharmacology ; Drug Resistance, Bacterial/Drug Resistance, Bacterial/Drug Resistance, Bacterial/*genetics ; Escherichia coli/Escherichia coli/Escherichia coli/*genetics

  • Source: Microbial drug resistance (Larchmont, N.Y.) [Microb Drug Resist] 2020 Nov; Vol. 26 (11), pp. 1326-1333. Date of Electronic Publication: 2020 Jan 31.Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 9508567 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Phase II trial evaluating the clinical efficacy of cefixime for treatment of active syphilis in non-pregnant women in Brazil (CeBra).

  • Authors : Taylor MM; Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland. .; U.S. Centers for Disease Control and Prevention, Division of STD Prevention, Atlanta, GA, USA. .

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Cefixime/Cefixime/Cefixime/*therapeutic use ; Syphilis/Syphilis/Syphilis/*drug therapy

  • Source: BMC infectious diseases [BMC Infect Dis] 2020 Jun 10; Vol. 20 (1), pp. 405. Date of Electronic Publication: 2020 Jun 10.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines.

  • Authors : Alirol E; Global Antibiotics Research and Development Partnership (GARDP), Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.; Wi TE

Subjects: Drug Resistance, Bacterial*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*pharmacology ; Gonorrhea/Gonorrhea/Gonorrhea/*drug therapy

  • Source: PLoS medicine [PLoS Med] 2017 Jul 26; Vol. 14 (7), pp. e1002366. Date of Electronic Publication: 2017 Jul 26 (Print Publication: 2017).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Intrahospital spread of carbapenem-resistant Pseudomonas aeruginosa in a University Hospital in Florianópolis, Santa Catarina, Brazil.

  • Authors : Scheffer MC; University Hospital, Federal University of Santa Catarina, Florianópolis, SC, Brazil.; Bazzo ML

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*pharmacology ; Carbapenems/Carbapenems/Carbapenems/*pharmacology ; Pseudomonas Infections/Pseudomonas Infections/Pseudomonas Infections/*microbiology

  • Source: Revista da Sociedade Brasileira de Medicina Tropical [Rev Soc Bras Med Trop] 2010 Jul-Aug; Vol. 43 (4), pp. 367-71.Publisher: Sociedade Brasileira de Medicina Tropical Country of Publication: Brazil NLM ID: 7507456 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-7 of  7 results for ""Bazzo ML""